Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
3(60%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
1
20%
Ph phase_2
3
60%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Terminated1
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
N/A1 (20.0%)

Trials by Status

recruiting240%
terminated120%
active_not_recruiting120%
completed120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
RADIATION
Total Trials
5